Business

Resverlogix Files 2017 Year-End Disclosure Documents and Announces Plans to Host a Symposium at the European Society of Cardiology Congress 2017

Resverlogix Files 2017 Year-End Disclosure Documents and Announces Plans to Host a Symposi...

articleResverlogix Corp.July 25, 20175/company/resverlogix-corp/news/resverlogix-files-2017-year-end-disclosure-documents-and-announces-plans-to-host-a-symposium-at-the-european-society-of-cardiology-congress-2017
Resverlogix Files 2017 Year-End Disclosure Documents and Announces Plans to Host a Symposium at the European Society of Cardiology Congress 2017

About this update from Resverlogix Corp.

[{"type":"text","content":"\n\n\n\nResverlogix Files 2017 Year-End Disclosure Documents and Announces Plans to Host a Symposium at the European Society of Cardiology Congress 2017\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prngen2{\nBORDER-BOTTOM:black 0pt; BORDER-LEFT:black 0pt; PADDING-LEFT:0.50em; PADDING-RIGHT:0.50em; VERTICAL-ALIGN: TOP; BORDER-TOP:black 0pt; BORDER-RIGHT:black 0pt\n}\n.prngen4{\nBORDER-BOTTOM:black 0pt; TEXT-ALIGN: RIGHT; BORDER-LEFT:black 0pt; PADDING-LEFT:0.50em; PADDING-RIGHT:0.50em; VERTICAL-ALIGN: BOTTOM; BORDER-TOP:black 0pt; BORDER-RIGHT:black 0pt\n}\n.prngen3{\nBORDER-BOTTOM:black 0pt; BORDER-LEFT:black 0pt; PADDING-LEFT:0.50em; PADDING-RIGHT:0.50em; VERTICAL-ALIGN: BOTTOM; BORDER-TOP:black 0pt; BORDER-RIGHT:black 0pt\n}\n.prnsbt0{\nBORDER-TOP:0pt\n}\n.prnsbr0{\nBORDER-RIGHT:0pt\n}\n.prnbcc{\nBORDER-COLLAPSE: COLLAPSE\n}\n.prnsbl0{\nBORDER-LEFT:0pt\n}\n.prnsbb0{\nBORDER-BOTTOM:0pt\n}\n\n\n\n\n\n\n\nCanada NewsWire\nCALGARY, July 25, 2017\n\n\n\nCALGARY, July 25, 2017 /CNW/ - Resverlogix Corp. (\"Resverlogix\" or the \"Company\") (TSX:RVX) announced today that it filed its audited Consolidated Financial Statements for the year ended April 30, 2017 and related Management's Discussion and Analysis with Canadian securities regulatory authorities. The Company has also filed its Annual Information Form for the year ended April 30, 2017. Copies of these documents may be obtained online at www.sedar.com, or the Company's website, www.resverlogix.com, or by emailing [email protected]. An additional corporate financial update will take place prior to August 28th, 2017.\n\nResverlogix to Host Symposium at the European Society of Cardiology Congress 2017\n\nThe Company also announced today that on Saturday, August 26, 2017, at the European Society of Cardiology (ESC) Congress in Barcelona, Spain, it will host a symposium titled: \"Managing Diabetes & CVD: Is epigenetics a new way forward?\"\n\nThe agenda and speakers are as follows:\n\nIntroductionLina Badimon, MD – Barcelona, Spain\n\nManaging high risk diabetes patients with cardiovascular disease: What works, and w...

More updates from Resverlogix Corp.